|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 175.30 EUR | +2.82% |
|
-2.39% | +41.14% |
| 07-20 | Salzgitter raises forecasts on stronger business and acquisition | DP |
| 07-14 | AURUBIS AG : Warburg Research reiterates its Buy rating | ZD |
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.31 | 7.61 | 0.57 | 3.95 | 5.12 | |||||
Return on Total Capital | 13.54 | 12.43 | 0.92 | 6.32 | 8.15 | |||||
Return On Equity % | 19.48 | 18.57 | 3.32 | 9.46 | 11.26 | |||||
Return on Common Equity | 19.48 | 18.56 | 3.32 | 9.46 | 11.27 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 11.27 | 9.73 | 6.35 | 9.74 | 10.13 | |||||
SG&A Margin | 3.44 | 3.08 | 3.26 | 3.69 | 3.39 | |||||
EBITDA Margin % | 6.08 | 5.65 | 1.57 | 3.95 | 4.92 | |||||
EBITA Margin % | 5.06 | 4.69 | 0.48 | 2.84 | 3.81 | |||||
EBIT Margin % | 4.95 | 4.62 | 0.39 | 2.78 | 3.75 | |||||
Income From Continuing Operations Margin % | 3.75 | 3.85 | 0.82 | 2.42 | 2.96 | |||||
Net Income Margin % | 3.75 | 3.85 | 0.82 | 2.42 | 2.96 | |||||
Net Avail. For Common Margin % | 3.75 | 3.85 | 0.82 | 2.42 | 2.96 | |||||
Normalized Net Income Margin | 3.15 | 2.91 | 0.26 | 1.8 | 2.34 | |||||
Levered Free Cash Flow Margin | 1.38 | -0.73 | -1.45 | -2.88 | -2.06 | |||||
Unlevered Free Cash Flow Margin | 1.45 | -0.68 | -1.36 | -2.75 | -1.98 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 2.69 | 2.64 | 2.33 | 2.28 | 2.18 | |||||
Fixed Assets Turnover | 10.85 | 12.03 | 10.64 | 9.64 | 9.06 | |||||
Receivables Turnover (Average Receivables) | 32.72 | 32.67 | 28.86 | 28.86 | 29.26 | |||||
Inventory Turnover (Average Inventory) | 5.5 | 5.27 | 4.61 | 4.47 | 4.33 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.38 | 2.35 | 2.38 | 2.15 | 2.21 | |||||
Quick Ratio | 0.77 | 0.65 | 0.61 | 0.49 | 0.46 | |||||
Operating Cash Flow to Current Liabilities | 0.42 | 0.13 | 0.29 | 0.24 | 0.29 | |||||
Days Sales Outstanding (Average Receivables) | 11.15 | 11.17 | 12.65 | 12.68 | 12.48 | |||||
Days Outstanding Inventory (Average Inventory) | 66.35 | 69.3 | 79.19 | 81.95 | 84.21 | |||||
Average Days Payable Outstanding | 31.14 | 30.98 | 36.21 | 36.82 | 36.55 | |||||
Cash Conversion Cycle (Average Days) | 46.36 | 49.49 | 55.62 | 57.81 | 60.13 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 16.89 | 7.69 | 6.19 | 8.41 | 10.79 | |||||
Total Debt / Total Capital | 14.45 | 7.14 | 5.83 | 7.76 | 9.74 | |||||
LT Debt/Equity | 12.9 | 4.91 | 4.81 | 5.17 | 9.63 | |||||
Long-Term Debt / Total Capital | 11.04 | 4.56 | 4.53 | 4.77 | 8.69 | |||||
Total Liabilities / Total Assets | 47.94 | 42.82 | 41.53 | 41.94 | 43.27 | |||||
EBIT / Interest Expense | 43.72 | 49.93 | 2.81 | 13.24 | 29.74 | |||||
EBITDA / Interest Expense | 53.77 | 61.12 | 11.32 | 18.83 | 39.52 | |||||
(EBITDA - Capex) / Interest Expense | 40.11 | 40.88 | -15 | -4.65 | 6.57 | |||||
Total Debt / EBITDA | 0.59 | 0.31 | 0.98 | 0.56 | 0.6 | |||||
Net Debt / EBITDA | -0.36 | -0.42 | -1.29 | 0.03 | 0.2 | |||||
Total Debt / (EBITDA - Capex) | 0.78 | 0.47 | -0.74 | -2.29 | 3.58 | |||||
Net Debt / (EBITDA - Capex) | -0.49 | -0.63 | 0.97 | -0.11 | 1.23 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 31.17 | 13.57 | -7.76 | 0.44 | 6.07 | |||||
Gross Profit, 1 Yr. Growth % | 34.29 | -1.93 | -39.82 | 54.06 | 10.27 | |||||
EBITDA, 1 Yr. Growth % | 70.37 | 2.1 | -74.35 | 154.03 | 34.33 | |||||
EBITA, 1 Yr. Growth % | 93.75 | 1.35 | -90.56 | 543.79 | 42.21 | |||||
EBIT, 1 Yr. Growth % | 94.38 | 1.83 | -92.2 | 630.95 | 43.1 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 131 | 16.64 | -80.26 | 195 | 29.57 | |||||
Net Income, 1 Yr. Growth % | 131.09 | 16.62 | -80.28 | 195.24 | 29.57 | |||||
Normalized Net Income, 1 Yr. Growth % | 101.62 | 3.28 | -91.79 | 611.98 | 37.78 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 135.88 | 16.67 | -80.28 | 195.22 | 29.51 | |||||
Accounts Receivable, 1 Yr. Growth % | 5.7 | 21.38 | -9.6 | 11.57 | -1.59 | |||||
Inventory, 1 Yr. Growth % | 13.82 | 26.7 | -4.32 | 4.31 | 13.14 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 0.28 | 4.52 | 4.09 | 17.48 | 8.88 | |||||
Total Assets, 1 Yr. Growth % | 19.51 | 12.61 | -2.52 | 8.08 | 12.64 | |||||
Tangible Book Value, 1 Yr. Growth % | 22.43 | 25.42 | -0.04 | 7.46 | 10.37 | |||||
Common Equity, 1 Yr. Growth % | 20.76 | 23.69 | -0.31 | 7.32 | 10.05 | |||||
Cash From Operations, 1 Yr. Growth % | 76.95 | -64.56 | 94.13 | -6.15 | 26.07 | |||||
Capital Expenditures, 1 Yr. Growth % | 9.78 | 37.48 | 80.09 | 35.47 | -10.51 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -442.44 | -149.01 | 82.19 | 99.28 | -24.34 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -538.69 | -143.35 | 85.93 | 102.29 | -23.78 | |||||
Dividend Per Share, 1 Yr. Growth % | 23.08 | 12.5 | -22.22 | 7.14 | 6.67 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 17.07 | 22.05 | 2.35 | -3.75 | 3.21 | |||||
Gross Profit, 2 Yr. CAGR % | 25.89 | 14.76 | -23.18 | -3.71 | 30.34 | |||||
EBITDA, 2 Yr. CAGR % | 61.18 | 34.05 | -48.83 | -19.5 | 83.07 | |||||
EBITA, 2 Yr. CAGR % | 81.21 | 42.89 | -69.08 | -25.19 | 202.82 | |||||
EBIT, 2 Yr. CAGR % | 80.18 | 43.52 | -71.81 | -25.31 | 223.57 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 78.35 | 64.15 | -52.02 | -23.69 | 95.42 | |||||
Net Income, 2 Yr. CAGR % | 78.38 | 64.17 | -52.04 | -23.7 | 95.56 | |||||
Normalized Net Income, 2 Yr. CAGR % | 79.01 | 45.29 | -70.88 | -24.33 | 213.46 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 81.05 | 65.9 | -52.03 | -23.7 | 95.52 | |||||
Accounts Receivable, 2 Yr. CAGR % | 14.67 | 13.27 | 4.75 | 0.43 | 4.79 | |||||
Inventory, 2 Yr. CAGR % | 18.61 | 20.09 | 10.1 | -0.1 | 8.64 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 10.84 | 2.38 | 4.31 | 10.58 | 13.08 | |||||
Total Assets, 2 Yr. CAGR % | 20.76 | 16.01 | 4.77 | 2.64 | 10.34 | |||||
Tangible Book Value, 2 Yr. CAGR % | 15.06 | 23.92 | 11.97 | 3.64 | 8.9 | |||||
Common Equity, 2 Yr. CAGR % | 15.12 | 22.21 | 11.04 | 3.43 | 8.68 | |||||
Cash From Operations, 2 Yr. CAGR % | 72.89 | -20.81 | -16.02 | 34.98 | 8.72 | |||||
Capital Expenditures, 2 Yr. CAGR % | 6.76 | 22.85 | 57.34 | 56.19 | 10.13 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 52.57 | 43.95 | -5.5 | 90.9 | 22.76 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 47.08 | 52.51 | -10.22 | 94.32 | 24.14 | |||||
Dividend Per Share, 2 Yr. CAGR % | 13.14 | 17.67 | -6.46 | -8.71 | 6.9 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 16.08 | 15.89 | 11.17 | 1.71 | -0.58 | |||||
Gross Profit, 3 Yr. CAGR % | 23.46 | 15.84 | -7.46 | -3.12 | 0.74 | |||||
EBITDA, 3 Yr. CAGR % | 29.92 | 39.93 | -22.75 | -12.86 | -5.09 | |||||
EBITA, 3 Yr. CAGR % | 34.31 | 51.25 | -42.24 | -17.22 | -7.28 | |||||
EBIT, 3 Yr. CAGR % | 34.29 | 50.96 | -45.62 | -17.18 | -7.21 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 32.67 | 54.81 | -18.98 | -12.1 | -8.99 | |||||
Net Income, 3 Yr. CAGR % | 28.29 | 54.82 | -19 | -12.11 | -8.97 | |||||
Normalized Net Income, 3 Yr. CAGR % | 37.06 | 49.7 | -44.24 | -16.07 | -7.55 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 34.16 | 56.39 | -18.43 | -12.1 | -8.99 | |||||
Accounts Receivable, 3 Yr. CAGR % | 23.17 | 16.86 | 5.07 | 6.98 | -0.25 | |||||
Inventory, 3 Yr. CAGR % | 18.61 | 21.25 | 11.33 | 8.14 | 4.13 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 11.74 | 8.7 | 2.95 | 8.52 | 10 | |||||
Total Assets, 3 Yr. CAGR % | 13.67 | 17.98 | 9.47 | 5.86 | 5.87 | |||||
Tangible Book Value, 3 Yr. CAGR % | 10.25 | 18.41 | 15.35 | 10.44 | 5.83 | |||||
Common Equity, 3 Yr. CAGR % | 10.29 | 17.91 | 14.19 | 9.79 | 5.6 | |||||
Cash From Operations, 3 Yr. CAGR % | 58.88 | 1.94 | 7.66 | -12.85 | 31.9 | |||||
Capital Expenditures, 3 Yr. CAGR % | 14.5 | 16.15 | 39.55 | 49.69 | 29.75 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -0.16 | 12.1 | 55.71 | 21.33 | 40.2 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 3.04 | 4.68 | 62.92 | 17.85 | 42.22 | |||||
Dividend Per Share, 3 Yr. CAGR % | 1.06 | 12.92 | 2.5 | -2.13 | -3.85 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 11.48 | 13.41 | 10.38 | 7.59 | 7.92 | |||||
Gross Profit, 5 Yr. CAGR % | 14.25 | 11.54 | 2.12 | 7.58 | 6.13 | |||||
EBITDA, 5 Yr. CAGR % | 27.32 | 14.19 | -9.91 | 12.17 | 8.97 | |||||
EBITA, 5 Yr. CAGR % | 38.19 | 15.64 | -24.77 | 14.13 | 10.23 | |||||
EBIT, 5 Yr. CAGR % | 37.86 | 15.35 | -27.5 | 13.93 | 10.48 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 37.77 | 17.57 | -11.67 | 16.66 | 15.23 | |||||
Net Income, 5 Yr. CAGR % | 38.13 | 15.29 | -13.45 | 16.66 | 15.24 | |||||
Normalized Net Income, 5 Yr. CAGR % | 39.48 | 16.29 | -26.03 | 13.95 | 10.77 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 38.94 | 18.38 | -11.09 | 17.36 | 15.72 | |||||
Accounts Receivable, 5 Yr. CAGR % | 16.2 | 11.74 | 15.44 | 9.99 | 4.95 | |||||
Inventory, 5 Yr. CAGR % | 10.53 | 15.19 | 15.13 | 12.21 | 10.24 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 4.29 | 5.47 | 8.7 | 9.45 | 6.89 | |||||
Total Assets, 5 Yr. CAGR % | 10.43 | 11.3 | 10.03 | 11.59 | 9.82 | |||||
Tangible Book Value, 5 Yr. CAGR % | 11.51 | 13.01 | 10.93 | 12.27 | 12.72 | |||||
Common Equity, 5 Yr. CAGR % | 11.6 | 12.5 | 10.59 | 11.89 | 11.95 | |||||
Cash From Operations, 5 Yr. CAGR % | 27.74 | -9.72 | 23.11 | 14.62 | 8.09 | |||||
Capital Expenditures, 5 Yr. CAGR % | 12.02 | 16.03 | 30.02 | 30.76 | 26.94 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 59.85 | -3.25 | 1.87 | 38.7 | 41.69 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 97.57 | -5.87 | 1.52 | 34.07 | 46.25 | |||||
Dividend Per Share, 5 Yr. CAGR % | 5.06 | 4.42 | -2.02 | 3.71 | 4.24 |
- Stock Market
- Stocks
- NDA Stock
- Financials Aurubis AG
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















